The University of Queensland

Inflammasome inhibitors as new first-in-class anti-inflammatory therapies (2022–2026)

Grant type:

NHMRC Investigator Grants

Researchers:

• 

  Professor Kate Schroder

  NHMRC Leadership Fellow - Group Lea
  

  Institute for Molecular Bioscience

Funded by:

National Health and Medical Research Council